Pyrido[3,2-d]pyrimidin-4-amine

Catalog No.: 
ACHRDE657
CAS No.: 
875233-01-5
Molecular Formula: 
C7H6N4
Molecular Weight: 
146.15
Pyrido[3,2-d]pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$909.00In stockInquiry
250mg95%$1514.00In stockInquiry
500mg95%$2163.00In stockInquiry
1g95%$3090.00In stockInquiry
5g95%$9579.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyrido[3,2-d]pyrimidin-4-amine
IUPAC Namepyrido[3,2-d]pyrimidin-4-amine
MDL No.MFCD19205848
Molecular FormulaC7H6N4
Molecular Weight146.15
SMILESNC1=C2C(C=CC=N2)=NC=N1
InChI KeyDGXAOSOMFMODCF-UHFFFAOYSA-N
SynonymPYRIDO[3,2-D]PYRIMIDIN-4-AMINE
CAS No.875233-01-5
PubChem CID55281763

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHRDE657 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSZF382 route compound structure diagram
    ACCSZF3821499166-63-0In Stock
  2. Then
  3. ACHRDE657 route product structure diagram
    ACHRDE657875233-01-5In Stock
Inquiry

2. ACHRDE657 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACHRDE657 route product structure diagram
    ACHRDE657875233-01-5In Stock
Inquiry

3. ACHRDE657 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACHRDE657 route product structure diagram
    ACHRDE657875233-01-5In Stock
Inquiry

Comments (0)